Loading...
COST-EFFECTIVENESS OF USING HEPATITIS C VIRUS VIREMIC HEARTS FOR TRANSPLANTATION INTO HCV-NEGATIVE RECIPIENTS
BACKGROUND: Outcomes following hepatitis C virus (HCV)-viremic heart transplantation into HCV-negative recipients with HCV treatment are good. We assessed cost-effectiveness between cohorts of transplant recipients willing and unwilling to receive HCV-viremic hearts. METHODS: Markov model simulating...
Saved in:
| Published in: | Am J Transplant |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8216294/ https://ncbi.nlm.nih.gov/pubmed/32777173 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ajt.16245 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|